ReviewAdvances in therapy2017
Unproven Therapies for Diabetes and Their Implications.
Review in Advances in therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Diabetes Management by Ayurvedic Practitioners Using a Clinical Guideline Versus Usual Practice: A Feasibility Cluster Randomized Trial in Nepal.Journal of diabetes research · 2026Trial
- The Pharmacokinetic Interaction Between Metformin and the Natural Product Goldenseal Is Metformin Dose-Dependent: A Three-Arm Crossover Study in Adults With Type 2 Diabetes.Clinical and translational science · 2025Trial
- Addressing Unmet Needs in the Management of Diabetes in Asia and Enhancing Diabetes Care Through the Use of Digital Technology: An Expert Opinion.Journal of the ASEAN Federation of Endocrine Societies · 2026Review
- A National Survey of Adherence to Glucose-Lowering Medication Among Adults With Diabetes in Indonesia.Tropical medicine & international health : TM & IH · 2026Article
- Diabetes management using a clinical guideline versus usual practice: a feasibility trial-based qualitative study among Ayurvedic practitioners and patients in Nepal.Therapeutic advances in endocrinology and metabolism · 2026Article
- Breaking the silence: factors influencing complementary therapy disclosure among diabetic outpatients in Taiwan.BMC complementary medicine and therapies · 2025Article
- Improving patient safety and access to healthcare: The role of pharmacist-managed clinics in optimizing therapeutic outcomes.Exploratory research in clinical and social pharmacy · 2024Review
- Review
- Prevalence of Complementary and Alternative Medicine Use and Its Associated Factors among Iranian Diabetic Patients: A Cross-Sectional Study.Current therapeutic research, clinical and experimental · 2024Article
- The Combinational Effect of Inulin and Resveratrol on the Oxidative Stress and Inflammation Level in a Rat Model of Diabetic Nephropathy.Current developments in nutrition · 2024Article
- Herb-Induced Liver Injury by Ayurvedic Medicine With Severe Lactic Acidosis: A Case Report.Cureus · 2023Article
- Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners.Frontiers in medicine · 2023Article
- Article
- Article
- Diabetic neuropathic pain induced by streptozotocin alters the expression profile of non-coding RNAs in the spinal cord of mice as determined by sequencing analysis.Experimental and therapeutic medicine · 2021Article
- Bioactive Compounds in Anti-Diabetic Plants: From Herbal Medicine to Modern Drug Discovery.Biology · 2020Review
- Herbal medicine from the perspective of type II diabetic patients and physicians: what is the relationship?BMC complementary medicine and therapies · 2020Article
- A qualitative study of facilitators and barriers to cardiovascular risk factor control in a semiurban population in India.Journal of family medicine and primary care · 2019Article
- Insights on Medical Nutrition Therapy for Type 2 Diabetes Mellitus: An Indian Perspective.Advances in therapy · 2019Review
- An update on natural compounds in the remedy of diabetes mellitus: A systematic review.Journal of traditional and complementary medicine · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes is a chronic disease and is one of the leading causes of morbidity and mortality worldwide. Being an ancient disease, many individuals follow complementary and alternative medicinal (CAM) therapies for either the cure or prevention of the disease. The popularity of these practices among the general public is in no way a testimony to their safety and efficacy. Due to the possibility of undesirable interactions with conventional medicines, it is imperative that patients are asked about CAM use during patient assessment. Patient- and physician-targeted awareness programs on various aspects of CAM use must be initiated to create a better understanding of evidence-based use of these practices. In addition, there should be guidelines in place based on clinical trial outcomes, and stricter regulations need to be enforced on CAM practices to ensure their safety and effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.